4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Structure Therapeutics Inc. (GPCR) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 281 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, GPCR reported $0M in revenue and ($141M) in net income.
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($187M) | ($158M) | ($103M) | ($53M) | — |
| Net Income | ($141M) | ($122M) | ($90M) | ($51M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($119M) | ($89M) | $14M | ($74M) | ($70M) |
| Net Income | ($106M) | ($76M) | $33M | ($66M) | ($62M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.6B | $903M | $482M | $98M | — |
| Total Liabilities | $68M | $38M | $29M | $213M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GPCR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms